 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/04/2022 |
$0.41 |
$0.42 |
$0.40 |
$0.41 |
283.70K | | 08/05/2022 |
$0.43 |
$0.43 |
$0.41 |
$0.42 |
282.10K | | 08/08/2022 |
$0.44 |
$0.45 |
$0.42 |
$0.43 |
207.70K | | 08/09/2022 |
$0.42 |
$0.45 |
$0.40 |
$0.41 |
287.20K | | 08/10/2022 |
$0.42 |
$0.47 |
$0.41 |
$0.46 |
3.21M |
|
|
| Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. | |
|
Aeglea BioTherapeutics (AGLE) has the following price history information. Looking back at AGLE historical stock prices for the last five trading days, on August 04, 2022, AGLE opened at $0.41, traded as high as $0.42 and as low as $0.40, and closed at $0.41. Trading volume was a total of 283.70K shares. On August 05, 2022, AGLE opened at $0.43, traded as high as $0.43 and as low as $0.41, and closed at $0.42. Trading volume was a total of 282.10K shares. On August 08, 2022, AGLE opened at $0.44, traded as high as $0.45 and as low as $0.42, and closed at $0.43. Trading volume was a total of 207.70K shares. On August 09, 2022, AGLE opened at $0.42, traded as high as $0.45 and as low as $0.40, and closed at $0.41. Trading volume was a total of 287.20K shares. On August 10, 2022, AGLE opened at $0.42, traded as high as $0.47 and as low as $0.41, and closed at $0.46. Trading volume was a total of 3.21M shares.
AGLE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aeglea BioTherapeutics shares, starting with a $10,000 purchase of AGLE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/08/2016 |
|
| End date: |
08/10/2022 |
|
| Start price/share: |
$11.99 |
|
| End price/share: |
$0.46 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.15% |
|
| Average Annual Total Return: |
-40.15% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$385.51 |
|
| Years: |
6.34 |
|
|
|
| Date |
Close |
| 08/04/2022 | $0.41 | | 08/05/2022 | $0.42 | | 08/08/2022 | $0.43 | | 08/09/2022 | $0.41 | | 08/10/2022 | $0.46 |
|
|
Free AGLE Email Alerts:
